Calithera Biosciences, Inc
CALA
CALA was delisted on the 1st of February, 2023.
90 hedge funds and large institutions have $100M invested in Calithera Biosciences, Inc in 2018 Q2 according to their latest regulatory filings, with 16 funds opening new positions, 25 increasing their positions, 33 reducing their positions, and 26 closing their positions.
10% less funds holding
Funds holding: 100 → 90 (-10)
24% less repeat investments, than reductions
Existing positions increased: 25 | Existing positions reduced: 33
26% less call options, than puts
Call options by funds: $535K | Put options by funds: $720K
29% less capital invested
Capital invested by funds: $142M → $100M (-$41.9M)
38% less first-time investments, than exits
New positions opened: 16 | Existing positions closed: 26
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
+$2.64M |
| 2 |
Dimensional Fund Advisors
Austin,
Texas
|
+$1.81M |
| 3 |
SI
Sofinnova Investments
Menlo Park,
California
|
+$1.57M |
| 4 |
AIM
Alambic Investment Management
Belvedere,
California
|
+$1.28M |
| 5 |
Prudential Financial
Newark,
New Jersey
|
+$1.17M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$4.29M |
| 2 |
Franklin Resources
San Mateo,
California
|
-$4.04M |
| 3 |
Millennium Management
New York
|
-$3.36M |
| 4 |
AQR Capital Management
Greenwich,
Connecticut
|
-$2.78M |
| 5 |
AC
Ascend Capital
Orinda,
California
|
-$1.74M |
CALA Hedge Fund Activity: Q2 2018 in Review
90 of the 4,368 institutional investors tracked by Wall St. Rank reported a position in Calithera Biosciences, Inc (CALA) for Q2 2018, worth a combined $100M — down 29% from $142M a quarter earlier.
Sellers outnumbered buyers: 26 funds closed out of CALA and 16 opened new positions — a net loss of 10 holders — while 33 trimmed existing stakes and 25 added.
The largest buyer was Federated Hermes, adding an estimated $2.64M. The largest seller was Fidelity Investments, exiting entirely with an estimated $4.29M sold.
- 90 institutional investors held Calithera Biosciences, Inc (CALA) as of Q2 2018, down from 100 in Q1 2018.
- Funds reported $100M of Calithera Biosciences, Inc stock for Q2 2018, down 29% quarter-over-quarter.
- 16 funds opened new Calithera Biosciences, Inc positions in Q2 2018 and 26 closed out, a net change of -10 holders.
- The largest Calithera Biosciences, Inc buyer in Q2 2018 was Federated Hermes, an estimated $2.64M added.
- The largest Calithera Biosciences, Inc seller in Q2 2018 was Fidelity Investments, an estimated $4.29M sold.
Based on aggregated 13F filings for Q2 2018.